Date | Compound | Laboratory | Indication | Type of Information |
---|---|---|---|---|
2015-01-13 | naltrexone | TaiwanJ Pharmaceuticals (Taiwan) | autoimmune hepatitis |
Granting of the orphan status in the US |
2015-02-23 | naltrexone | Allodynic Therapeutics (USA - FL) | postherpetic neuralgia |
Granting of the orphan status in the US |
2015-02-11 | paromomycin | The Surgeon General, Dept. of the Army USAMRMC (USA - MD) | cutaneous leishmaniasis |
Granting of the orphan status in the US |
2015-12-29 | ozanimod | Receptos (USA - CA) now Celgene (USA _ NJ) | pediatric (0 through 16 years of age) ulcerative colitis |
Granting of the orphan status in the US |
2015-02-10 | omeprazole-lansoprazole with buffer | Effexus Pharmaceuticals (USA - KS) | esophageal ulcers |
Granting of the orphan status in the US |
2015-12-29 | noscapine | KineMed (USA - CA) | amyotrophic lateral sclerosis |
Granting of the orphan status in the US |
2017-05-05 | pembrolizumab (MK-3475) | Merck&Co (USA - NJ) |
|
Granting of a Market Authorisation in the EU |
2015-02-24 | pelareorep - human reovirus type 3 Dearing strain | Oncolytics Biotech (Canada) | primary peritoneal cancer |
Granting of the orphan status in the US |
2015-02-24 | pelareorep - human reovirus type 3 Dearing strain | Oncolytics Biotech (Canada) | fallopian tube cancer |
Granting of the orphan status in the US |
2016-03-21 | ubenimex | Eiger BioPharmaceuticals (USA - CA) | pulmonary arterial hypertension (PAH) |
Granting of the orphan status in the EU |
2017-06-15 | tirapazamine | Teclison (USA - NJ) PhaRA (Belgium) | hepatocellular carcinoma | Positive opinion for the granting of the orphan status in the EU |
2015-12-29 | treprostinil sodium solution enclosed within a pre-filled, pre-programmed, single-use, electronically-controlled infusion pump | SteadyMed Therapeutics (USA - CA) | pulmonary arterial hypertension (PAH) |
Granting of the orphan status in the US |
2014-03-26 | treprostinil sodium solution enclosed within a pre-filled, pre-programmed, single-use, electronically-controlled infusion pump | United Therapeutics (USA - MD) | pulmonary arterial hypertension (PAH) |
Granting of a Market Authorisation in Japan |
2015-01-26 | tarextumab | OncoMed Pharmaceuticals (USA - CA) | small cell lung cancer |
Granting of the orphan status in the US |
2015-02-19 | polidocanol | Provensis (UK) | congenital venous malformations |
Granting of the orphan status in the US |
2015-02-11 | recombinant humanized anti-interleukin 13 (IL-13) monoclonal antibody | Receptos (USA - CA) now Celgene (USA _ NJ) | eosinophilic esophagitis |
Granting of the orphan status in the US |
2015-03-03 | recombinant activated Factor X variant | Pfizer (USA - NY) | intracerebral hemorrhage |
Granting of the orphan status in the US |
2015-02-24 | propranolol hydrochloride and etodolac | Vicus Therapeutics (USA - NJ) | hepatocellular carcinoma | Granting of the orphan status in the US |
2016-03-21 | recombinant adeno-associated virus serotype AAV8 vector encoding human ornithine transcarbamylase | Dimension Therapeutics (USA - MA)/Pharma Gateway (Sweden) | ornithine transcarbamylase deficiency |
Granting of the orphan status in the EU |
2016-06-02 | setmelanotide | Rhythm Metabolics (USA - MA)/TMC Pharma Services (UK) | Prader-Willi syndrome |
Granting of the orphan status in the EU |
© 2024 Biopharmanalyses - Powered by Samacom+